health care sector
DESCRIPTION
Health care sector. Suyang Yang Huiting Wang. Agenda. Sector Overview Business Analysis Financial Analysis Valuation Analysis Recommendation Q&A. Health Care Sector. Stocks relates to medical & healthcare goods or services Health Care Sector includes: Hospital management firms - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/1.jpg)
HEALTH CARE SECTOR
Suyang YangHuiting Wang
![Page 2: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/2.jpg)
AGENDA
Sector Overview Business Analysis Financial Analysis Valuation Analysis Recommendation Q&A
![Page 3: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/3.jpg)
HEALTH CARE SECTOR
Stocks relates to medical & healthcare goods or services
Health Care Sector includes: Hospital management firms Health maintenance organizations (HMOs) Biotechnology Medical products
![Page 4: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/4.jpg)
SECTOR SIZE
Sector Number of Constituents Adjusted Market Cap. In $ Mil
Energy 40 1,127,143 Materials 30 309,561 Industrials 59 920,442
Consumer Discretionary 78 830,996 Consumer Staples 41 1,089,057
Health Care 53 1,153,936
Financials 79 1,337,608 Information Technology 76 1,737,657
Telecommunications Services 9 281,594 Utilities 35 336,174
![Page 5: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/5.jpg)
SECTOR WEIGHT
S&P 500 SIM
![Page 6: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/6.jpg)
SECTOR WEIGHTSector S&P 500 Weight SIM Weight Change
Energy 12.35% 12.80% 0.45%
Materials 3.39% 4.52% 1.13%
Industrials 10.09% 11.97% 1.88%Consumer Discretionary 9.11% 7.51% -1.60%
Consumer Staples 11.94% 12.23% 0.29%
Health Care 12.65% 13.13% 0.48%
Financials 14.66% 6.59% -8.07%Information Technology 19.04% 21.97% 2.93%
Telecom Services 3.09% 3.51% 0.42%
Utilities 3.68% 3.19% -0.49%
![Page 7: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/7.jpg)
HEALTH CARE INDUSTRIES
![Page 8: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/8.jpg)
HEALTH CARE INDUSTRY
Pharmaceutical is the KEY driver of the sector
Represent 51.7% of Health Care Sector & 6.6% of S&P 500
by Mkt. Cap
Industry develops, produces, and markets drugs licensed for
use as medications
Pharmaceutical Sales include:
Prescribed drugs
OTC medications
![Page 9: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/9.jpg)
TOP HEALTH CARE COMPANIESCompany Ticker % of S&P500 Industry
Market Cap (In $ Bil)
Johnson & Johnson
JNJ 1.79% Pharmaceutical 163.9
Pfizer PFE 1.49% Pharmaceutical 136.7
Abbott Laboratories
ABT 0.86% Pharmaceutical 78.7
Merck & Co. MRK 0.72% Pharmaceutical 65.9
Amgen AMGN 0.58% Biotechnology 53.2
Teva Pharmaceutical Industries Ltd.
TEVA Pharmaceutical 47.1
Schering-Plough SGP 0.51% Pharmaceutical 46.4
Medtronic MDT 0.44%HealthCare-Equipment
40.0
Gilead Sciences GILD 0.42% Biotechnology 38.6
![Page 10: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/10.jpg)
SIM HOLDINGS
JNJ & TEVA are two top holdings of SIM Portfolio
Company Ticker % of Asset IndustryMarket Cap
(In $ Bil)Cardinal Health
Inc.CAH 2.05% HC-Distributor 10.3
CareFusion Corp.
CFN 0.81% HC-Equipment 5.0
Gilead Sciences Inc.
GILD 3.12% Biotechnology 38.6
Johnson & Johnson Co.
JNJ 3.73% Pharmaceutical 163.9
Teva Pharmaceutical Industries Ltd.
TEVA 3.42% Pharmaceutical 47.1
![Page 11: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/11.jpg)
BUSINESS ANALYSIS
Overall, Health Care sector is in Maturity stage of life cycle Pharmaceutical Industry(51.7%) is in the grey area between Growth
and Maturity Health Care-Equipment(14.52%) is in Maturity stage Biotechnology Industry(12.5%) is in Growth stage
![Page 12: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/12.jpg)
5 FORCE
Generic DrugsSubstitutes
Concentrate on several large
companies: JNJ, PFE, MRK,ABT (40%)
Supplier Power
Low- Major supplier is chemical industry and have competitive suppliers
Barriers to Enter
High barriers to enter, due to huge demand for R&D
Costly Regulations Patent
Buyer Power
Low- no buyer has any particular influence on product or price
![Page 13: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/13.jpg)
PATENT EXPIRATION & GENERIC DRUGS 20 YR Patent Length, 10 yr avg for FDA approval 2009-2014, expires @ the rate of 3 drugs/year Generic Drugs: cost-saving alternative
![Page 14: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/14.jpg)
5 FORCE
Generic DrugsSubstitutes
Concentrate on several large
companies: JNJ, PFE, MRK,ABT (40%)
Supplier Power
Low- Major supplier is chemical industry and have competitive suppliers
Barriers to Enter
High barriers to enter, due to huge demand for R&D
Costly Regulations Patent
Buyer Power
Low- no buyer has major influence on product or price
![Page 15: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/15.jpg)
FACTORS INFLUENCES HEALTH CARE SECTOR
![Page 16: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/16.jpg)
DEMOGRAPHICS & BABY BOOMERS
Demographic trend shows that there is a very big potential market for Health Care Sector in the near future. Also, Baby boomers are getting older.
![Page 17: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/17.jpg)
NATIONAL HEALTH EXPENDITURE
Health Expenditure is in an up trend, which indicate future market of Health Care Sector
![Page 18: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/18.jpg)
EXCHANGE RATE
Euro/USD Ratio Chart
![Page 19: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/19.jpg)
HEALTHCARE REFORM
Period of controversy (UNCERTAINTY) Worst-case scenario are priced in Sector is over-sold
16.0%-12.7%
21.0%-13.1%
![Page 20: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/20.jpg)
FINANCIAL ANALYSIS-NPM
SPX: 8.0%
HCX: 10.0%
DRUGS: 22.0%
BIOTK: 30% for 3 years
![Page 21: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/21.jpg)
FINANCIAL ANALYSIS-NPM
![Page 22: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/22.jpg)
FINANCIAL ANALYSIS-ROE
HCX:24.1%SPX: 11.0%DRUGS: 28.5%BIOTK: 23.7%HCDIS: 17.0%HCEQP: 19.2%
![Page 23: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/23.jpg)
FINANCIAL ANALYSIS-CF
Good job: BIOTK
Stable: DURGS
![Page 24: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/24.jpg)
FINANCIAL ANALYSIS-EBITDA
Current 2009:
HCX: 16.9%
SPX: 17.4%
![Page 25: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/25.jpg)
FINANCIAL ANALYSIS-Revenue Growth
HCX Revenue is increasing at average 9% for the past 5 years.
![Page 26: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/26.jpg)
VALUATION ANALYSIS
![Page 27: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/27.jpg)
VALUATION ANALYSIS-Sector fP/EAbsolute Price to Earnings Ratio
Price to Earnings Relative to S&P 500
High: 39.7Low: 10.0Median:
17.9Current
11.6
High: 1.6Low: 0.69
Median: 1.1Current
0.71
![Page 28: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/28.jpg)
VALUATION ANALYSIS-Industry fP/EDrugs Price to Earnings Relative to S&P 500
Biotk Price to Earnings Relative to S&P 500
High: 1.1Low: 0.64
Median: 1.0Current
0.65
High: 3.2Low: 0.78
Median: 1.5Current
0.78
![Page 29: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/29.jpg)
VALUATION ANALYSIS-Industry fP/EHcdis Price to Earnings Relative to S&P 500
Hceqp Price to Earnings Relative to S&P 500
High: 1.6Low: 0.65Median:
0.99Current
0.82
High: 1.8Low: 0.79
Median: 1.3Current
0.84
![Page 30: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/30.jpg)
VALUATION ANALYSIS-Sector P/S
Absolute Price to Sales Ratio
Price to Sales Relative to S&P 500
High: 4.7Low: 1.0
Median: 2.0Current 1.2
High: 2.4Low: 1.1
Median: 1.3Current 1.1
![Page 31: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/31.jpg)
VALUATION ANALYSIS-Industry P/SDrugs Price to Sales Relative to S&P 500
Biotk Price to Sales Relative to S&P 500
High: 3.9Low: 2.1
Median: 2.5Current 2.3
High: 10.5Low: 3.8
Median: 5.5Current 4.0
![Page 32: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/32.jpg)
VALUATION ANALYSIS-Industry P/SHcdis Price to Sales Relative to S&P 500
Hceqp Price to Sales Relative to S&P 500
High: 0.4Low: 0.1
Median: 0.2Current 0.1
High: 3.6Low: 1.8
Median: 2.7Current 2.3
![Page 33: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/33.jpg)
VALUATION ANALYSIS-Sector P/BAbsolute Price to Book Value Ratio
Price to Book Value Relative to S&P 500
High: 10.1Low: 2.2
Median: 4.2Current 2.9
High: 2.5Low: 1.2
Median: 1.4Current 1.4
![Page 34: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/34.jpg)
VALUATION ANALYSIS-Industry P/BDrugs Price to Book Relative to S&P 500
Biotk Price to Book Relative to S&P 500
High: 3.3Low: 1.2
Median: 1.5Current 1.4
High: 4.9Low: 1.2
Median: 1.8Current 1.5
![Page 35: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/35.jpg)
VALUATION ANALYSIS-Industry P/BHcdis Price to Book Relative to S&P 500
Hceqp Price to Book Relative to S&P 500
High: 1.5Low: 0.5
Median: 0.9Current 0.9
High: 2.6Low: 1.2
Median: 1.9Current 1.3
![Page 36: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/36.jpg)
VALUATION ANALYSIS-Sector P/CFAbsolute Price to Cash Flows Ratio
Price to Cash Flow Relative to S&P 500
High: 163.1Low: 7.6Median:
14.4Current 9.4
High: 9.8Low: 0.9
Median: 1.3Current 0.9
![Page 37: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/37.jpg)
VALUATION ANALYSIS-Industry P/CFDrugs Price to Cash Flow Relative to S&P 500
Biotk Price to Cash Flow Relative to S&P 500
High: 2.0Low: 0.8Median:
1.2Current
0.8
High: 3.8Low: 1.1
Median: 2.0Current 1.1
![Page 38: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/38.jpg)
VALUATION ANALYSIS-Industry P/CFHcdis Price to Cash Flow Relative to S&P 500
Hceqp Price to Cash Flow Relative to S&P 500
High: 2.0Low: 0.7Median:
1.3Current
0.8
High: 2.0Low: 1.1
Median: 1.6Current 1.1
![Page 39: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/39.jpg)
VALUATION ANALYSIS-Sector Summary
Absolute Basis High Low Median Current Difference Under/Over
P/Trailing E 19.6 9.9 17.8 12.0 (5.8) Under
P/Forward E 18.6 10.0 16.7 11.6 (5.1) Under
P/B 4.3 2.2 3.8 2.9 (0.9) Under
P/S 2.0 1.0 1.8 1.2 (0.6) Under
P/CF 15.5 7.6 13.3 9.4 (3.9) Under
Relative to SP500 High Low Median Current Difference Under/Over
P/Trailing E 1.2 0.7 1.1 0.7 (0.4) Under
P/Forward E 1.2 0.7 1.1 0.7 (0.4) Under
P/B 1.6 1.2 1.3 1.4 0.1 Over
P/S 1.6 1.1 1.2 1.1 (0.1) Under
P/CF 1.4 0.9 1.2 0.9 (0.3) Under
![Page 40: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/40.jpg)
Recommendations
Current SIM Weight Current S&P 500 Weight
13.13% 12.65%
• Short Term: Increase 52 basis point bring the SIM
portfolio 100 basis point overweight relative to S&P 500.
• Long Term: Decrease weight when economy shows definite
signs of improvement due to the defensive nature of Health Care
sector.
![Page 41: Health care sector](https://reader034.vdocument.in/reader034/viewer/2022051517/56815971550346895dc6b507/html5/thumbnails/41.jpg)
Questions?
Thank You!